Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2004-04-30
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A National Registry of Patients With Hepatocellular Carcinoma
NCT00178867
Liver and Biliary Tumor Tissue Registry
NCT02917759
Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma
NCT02585687
HCC Innervation Assessment
NCT06886763
Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors
NCT01922323
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. how drugs/medicines affect the liver and
2. the effects of storing liver cells in the cold or freezing.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* A diagnosis of hepatocellular carcinoma without negative serologies
* A diagnosis of cholangiocarcinoma, where the total bilirubin has ever been greater or equal to 3.0
* The presence of a biliary drainage tube
* Active sepsis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sunil Geevarghese
MD, MSCI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sunil K Geevarghese, MD, MSCI
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
040220
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.